MicroPort MedBot Expects RMB28-40 Million H1 2026 Profit After 200%+ Revenue Jump

Bulletin Express07-22

Shanghai MicroPort MedBot (Group) Co., Ltd. released a positive profit alert for the six months ended 30 June 2026, projecting a net profit of approximately RMB28.00 million to RMB40.00 million. The company posted a RMB115.00 million net loss in the same period of 2025, making the upcoming results its first semi-annual profit.

Revenue is expected to rise by about 200%–230% year on year, driven primarily by the Toumai Laparoscopic Surgical Robot. Overseas sales of Toumai recorded growth of more than 450%, supported by expanded market coverage and collaboration with MicroPort’s international distribution channels.

Gross profit margin is set to improve by more than 15 percentage points, reflecting fixed-cost dilution from larger production volumes, manufacturing process optimisation that lowered labour and material costs, and a richer mix of higher-margin consumables.

The operating expense-to-revenue ratio fell sharply during the period as ongoing expense control and resource allocation measures enhanced overall efficiency.

All figures are based on unaudited management accounts and may be adjusted. Full interim results are scheduled for release on or before 31 August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1194291108?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 22:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194291108","market":"us","top_or_hot":-1,"title":"MicroPort MedBot Expects RMB28-40 Million H1 2026 Profit After 200%+ Revenue Jump","media":"Bulletin Express","content":"<p>Shanghai MicroPort MedBot (Group) Co., Ltd. released a positive profit alert for the six months ended 30 June 2026, projecting a net profit of approximately RMB28.00 million to RMB40.00 million. The company posted a RMB115.00 million net loss in the same period of 2025, making the upcoming results its first semi-annual profit.</p>\n<p>Revenue is expected to rise by about 200%–230% year on year, driven primarily by the Toumai Laparoscopic Surgical Robot. Overseas sales of Toumai recorded growth of more than 450%, supported by expanded market coverage and collaboration with MicroPort’s international distribution channels.</p>\n<p>Gross profit margin is set to improve by more than 15 percentage points, reflecting fixed-cost dilution from larger production volumes, manufacturing process optimisation that lowered labour and material costs, and a richer mix of higher-margin consumables.</p>\n<p>The operating expense-to-revenue ratio fell sharply during the period as ongoing expense control and resource allocation measures enhanced overall efficiency.</p>\n<p>All figures are based on unaudited management accounts and may be adjusted. Full interim results are scheduled for release on or before 31 August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort MedBot Expects RMB28-40 Million H1 2026 Profit After 200%+ Revenue Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort MedBot Expects RMB28-40 Million H1 2026 Profit After 200%+ Revenue Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-22 22:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai MicroPort MedBot (Group) Co., Ltd. released a positive profit alert for the six months ended 30 June 2026, projecting a net profit of approximately RMB28.00 million to RMB40.00 million. The company posted a RMB115.00 million net loss in the same period of 2025, making the upcoming results its first semi-annual profit.</p>\n<p>Revenue is expected to rise by about 200%–230% year on year, driven primarily by the Toumai Laparoscopic Surgical Robot. Overseas sales of Toumai recorded growth of more than 450%, supported by expanded market coverage and collaboration with MicroPort’s international distribution channels.</p>\n<p>Gross profit margin is set to improve by more than 15 percentage points, reflecting fixed-cost dilution from larger production volumes, manufacturing process optimisation that lowered labour and material costs, and a richer mix of higher-margin consumables.</p>\n<p>The operating expense-to-revenue ratio fell sharply during the period as ongoing expense control and resource allocation measures enhanced overall efficiency.</p>\n<p>All figures are based on unaudited management accounts and may be adjusted. Full interim results are scheduled for release on or before 31 August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02252","symbol_name":"微创机器人-B","start_time":0,"source_url":"","article_id":"1194291108","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194291108","pubTimestamp":1784731271,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai MicroPort MedBot (Group) Co., Ltd. released a positive profit alert for the six months ended 30 June 2026, projecting a net profit of approximately RMB28.00 million to RMB40.00 million. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02252":"微创机器人-B"},"translate_title":"微创医疗机器人预计收入增长200%以上后，2026年上半年利润将达到2800万至4000万元人民币","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"Shanghai MicroPort MedBot (Group) Co., Ltd. released a positive profit alert for the six months ended 30 June 2026, projecting a net profit of approximately RMB28.00 million to RMB40.00 million. The company posted a RMB115.00 million net loss in the same period of 2025, making the upcoming results its first semi-annual profit.\nRevenue is expected to rise by about 200%–230% year on year, driven primarily by the Toumai Laparoscopic Surgical Robot. Overseas sales of Toumai recorded growth of more than 450%, supported by expanded market coverage and collaboration with MicroPort’s international distribution channels.\nGross profit margin is set to improve by more than 15 percentage points, reflecting fixed-cost dilution from larger production volumes, manufacturing process optimisation that lowered labour and material costs, and a richer mix of higher-margin consumables.\nThe operating expense-to-revenue ratio fell sharply during the period as ongoing expense control and resource allocation measures enhanced overall efficiency.\nAll figures are based on unaudited management accounts and may be adjusted. Full interim results are scheduled for release on or before 31 August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194291108","isCrawlerRequest":true}